Bente Juel Christiansen

PersonUnit number: 4000179809
Piazzetta da la val da Gagg 10 6922 Morcote(Switzerland)
1
Ownership
28
Board positions
7
Director positions
6
Other roles
383
People in network

People in network(383)

People who held roles at the same companies, or who co-own the same companies

Claus Henrik Christiansen
C.C. CONSULTING A/S, C.C. CONSULTING A/S, IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S, NORDIC BIOSCIENCE CLINICAL STUDIES A/S, NORDIC BIOSCIENCE A/S, DEN DANSKE FORSKNINGSFOND, DEN DANSKE FORSKNINGSFOND, NORDIC BIOSCIENCE HOLDING A/S, NORDIC BIOSCIENCE HOLDING A/S, NORDIC BIOSCIENCE HOLDING A/S and 21 more
Thomas Nielsen
NORDIC BIOSCIENCE CLINICAL STUDIES A/S, NORDIC BIOSCIENCE CLINICAL STUDIES A/S, NORDIC BIOSCIENCE A/S, DEN DANSKE FORSKNINGSFOND, NORDIC BIOSCIENCE HOLDING A/S, Sanos A/S, NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S, NBCD A/S, NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S, NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S and 6 more
Henrik Bernt Sanders
C.C. CONSULTING A/S, DEN DANSKE FORSKNINGSFOND, NORDIC BIOSCIENCE HOLDING A/S, Sanos A/S, NBCD A/S, Romarine ApS, Sanos Holding A/S, The Art Residency P/S, Gl. Holtegaard P/S

Ownership(1)

Romarine ApS
CVR: 37126306
EJERREGISTER
50-66,65%
Ownership
Active

Board positions(4)

NORDIC BIOSCIENCE A/S
CVR: 30799968
BESTYRELSESMEDLEM
Active
Since 15. okt. 2010
Gl. Holtegaard P/S
CVR: 45465365
BESTYRELSESMEDLEM
Active
Since 14. mar. 2025
The Art Residency P/S
CVR: 45400948
BESTYRELSESMEDLEM
Active
Since 14. feb. 2025
Romarine ApS
CVR: 37126306
BESTYRELSESMEDLEM
Active
Since 29. feb. 2024

Director positions(5)

DEN DANSKE FORSKNINGSFOND
CVR: 16205036
DIREKTØR
Active
Since 1. jan. 2023
Gl. Holtegaard P/S
CVR: 45465365
DIREKTØR
Active
Since 14. mar. 2025
The Art Residency P/S
CVR: 45400948
DIREKTØR
Active
Since 14. feb. 2025
Miramare ApS
CVR: 38596136
DIREKTØR
Active
Since 31. mar. 2023
Active
Since 13. feb. 2025

Other roles(3)

Active
Since 1. sep. 1998
NORDIC BIOSCIENCE HOLDING A/S
CVR: 30511271
EJERREGISTER
Active
Sanos Holding A/S
CVR: 41409029
EJERREGISTER
Active

Indirect ownership(10)

Companies owned indirectly through ownership chains.

Miramare ApS
CVR: 38596136
50-66,65%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Miramare ApS(100%)
Oregano ApS
CVR: 46164946
50-66,65%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Oregano ApS(100%)
33,33-49,99%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
33,33-49,99%
Effective ownership
Depth: 2
Ownership path:
Alma Madmarked A/S
CVR: 44892723
33,33-49,99%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Alma Madmarked A/S(66,66-89,99%)
Symic OA ApS
CVR: 40848460
25-33,32%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Symic OA ApS(50-66,65%)
Nordic Clays ApS
CVR: 42858579
25-33,32%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Nordic Clays ApS(50-66,65%)
Spora ApS
CVR: 44348454
5-9,99%
Effective ownership
Depth: 1
Ownership path:
Romarine ApS(50-66,65%)
Spora ApS(15-19,99%)
2,5%
Effective ownership
Depth: 1
Ownership path:
2,5%
Effective ownership
Depth: 1
Ownership path:

Former board positions(24)

OSTEOMETER A/S
CVR: 13191344
BESTYRELSE
Ended
Since 10. jul. 1989
Until 11. maj 1995
OSTEOMETER A/S
CVR: 13191344
DIREKTION
Ended
Since 10. jul. 1989
Until 11. maj 1995
Center for Clinical and Basic Research A/S
CVR: 21142743
BESTYRELSESMEDLEM
Ended
Since 1. sep. 1998
Until 15. jan. 1999
NORDIC BIOSCIENCE HOLDING A/S
CVR: 30511271
BESTYRELSESMEDLEM
Ended
Since 29. jun. 2007
Until 17. maj 2013
DEN DANSKE FORSKNINGSFOND
CVR: 16205036
NÆSTFORMAND
Ended
Since 18. aug. 1992
Until 28. aug. 1996
OSTEOPRESS ApS
CVR: 10311470
BESTYRELSE
Dissolved
Ended
Since 1. jul. 1986
Until 12. maj 2016
OSTEOPRESS ApS
CVR: 10311470
DIREKTION
Dissolved
Ended
Since 1. jul. 1986
Until 12. maj 2016
OSTEOMETER MEDITECH A/S
CVR: 16583995
BESTYRELSE
Dissolved
Ended
Since 1. nov. 1992
Until 22. apr. 1996
OSTEOMETER MEDITECH A/S
CVR: 16583995
DIREKTION
Dissolved
Ended
Since 1. nov. 1992
Until 11. maj 1995
Ended
Since 25. jun. 1997
Until 6. dec. 2002
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
CVR: 16584037
BESTYRELSE
Dissolved
Ended
Since 1. nov. 1992
Until 14. nov. 1996
IMMUNODIAGNOSTIC SYSTEMS NORDIC A/S
CVR: 16584037
DIREKTION
Dissolved
Ended
Since 1. nov. 1992
Until 23. apr. 1996
Sunshine Enterprise Holding A/S
CVR: 25516397
BESTYRELSESMEDLEM
Ended
Since 15. dec. 2003
Until 12. sep. 2006
NORDIC BIOSCIENCE ASSAY DEVELOPMENT A/S
CVR: 30582497
BESTYRELSE
Dissolved
Ended
Since 7. maj 2007
Until 10. sep. 2012
NORDIC BIOSCIENCE LABORATORY A/S
CVR: 30724429
BESTYRELSE
Dissolved
Ended
Since 17. jul. 2007
Until 1. nov. 2008
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT A/S
CVR: 27987869
BESTYRELSE
Dissolved
Ended
Since 4. sep. 2006
Until 10. sep. 2012
Sanos Holding A/S
CVR: 41409029
BESTYRELSESMEDLEM
Ended
Since 3. jun. 2020
Until 10. dec. 2020
CACLAURIIS ApS
CVR: 27917003
DIREKTION
Dissolved
Ended
Since 15. jun. 2004
Until 2. maj 2011
C.C. CONSULTING A/S
CVR: 73488710
BESTYRELSESMEDLEM
Dissolved
Ended
Since 13. feb. 1984
Until 29. jun. 2015
Sanos A/S
CVR: 26997933
BESTYRELSESMEDLEM
Ended
Since 11. jan. 2018
Until 10. dec. 2020
CCBR GROUP A/S
CVR: 34465703
BESTYRELSE
Dissolved
Ended
Since 31. aug. 2012
Until 2. jul. 2014
NORDIC BIOSCIENCE CLINICAL DEVELOPMENT VII A/S
CVR: 33249098
DIREKTION
Dissolved
Ended
Since 18. okt. 2010
Until 1. jan. 2014
NORDIC BIOSCIENCE CLINICAL STUDIES A/S
CVR: 21144347
BESTYRELSE
Dissolved
Ended
Since 3. jun. 2004
Until 2. jul. 2014
NBCD A/S
CVR: 30582462
BESTYRELSESMEDLEM
Ended
Since 1. jul. 2020
Until 10. dec. 2020

Former director positions(2)

C.C. CONSULTING A/S
CVR: 73488710
DIREKTØR
Dissolved
Ended
Since 13. feb. 1984
Until 6. okt. 1995
NBCD A/S
CVR: 30582462
DIREKTØR
Ended
Since 3. dec. 2010
Until 1. jan. 2014

Former roles(3)

OSTEOMETER A/S
CVR: 13191344
STIFTERE
Ended
Since 10. jul. 1989
Until 11. maj 1995
CACLAURIIS I/S V/CLAUS OG BENTE CHRISTIANSEN
CVR: 14227806
INTERESSENTER
Dissolved
Ended
Since 1. maj 1990
Until 31. dec. 2003
CACLAURIIS ApS
CVR: 27917003
STIFTERE
Dissolved
Ended
Since 15. jun. 2004
Until 2. maj 2011